Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Can recombinant thrombomodulin play a preventive role for veno-occlusive disease after haematopoietic stem cell transplantation?

Nomura S, Ozasa R, Nakanishi T, Fujita S, Miyaji M, Mori S, Yokoi T, Ito T, Ishii K.

Thromb Haemost. 2011 Jun;105(6):1118-20. doi: 10.1160/TH10-12-0802. Epub 2011 Apr 7. No abstract available.

PMID:
21647533
[PubMed - indexed for MEDLINE]
2.

Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?

Villalón L, Avello AG, César J, Odriozola J, López J, Oteyza JP, Laraña JG, Cantalapiedra A, Navarro JL.

Thromb Res. 2000 Sep 1;99(5):439-46.

PMID:
10973671
[PubMed - indexed for MEDLINE]
3.

Hemostatic abnormalities and changes following bone marrow transplantation.

Matsumoto T, Wada H, Nishiyama H, Hirano T, Sakakura M, Nishii K, Masuya M, Kageyama S, Tamaki S, Nakase K, Nobori T, Shiku H.

Clin Appl Thromb Hemost. 2004 Oct;10(4):341-50.

PMID:
15497020
[PubMed - indexed for MEDLINE]
4.

Immunogenomics and proteomics in hematopoietic stem cell transplantation: predicting post-hematopoietic stem cell transplant complications.

Weissinger EM, Dickinson AM.

Cancer Treat Res. 2009;144:95-129. doi: 10.1007/978-0-387-78580-6_5. Review. No abstract available.

PMID:
19779872
[PubMed - indexed for MEDLINE]
5.

Bibliography. Current world literature. Transplantation.

[No authors listed]

Curr Opin Oncol. 2000 Mar;12(2):B43-9. No abstract available.

PMID:
10750732
[PubMed - indexed for MEDLINE]
6.

IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.

Ferrà C, de Sanjosé S, Gallardo D, Berlanga JJ, Rueda F, Marìn D, de la Banda E, Ancìn I, Peris J, Garcìa J, Grañena A.

Haematologica. 1998 Dec;83(12):1082-7.

PMID:
9949625
[PubMed - indexed for MEDLINE]
Free Article
7.

Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation.

Woywodt A, Haubitz M, Buchholz S, Hertenstein B.

Bone Marrow Transplant. 2004 Dec;34(12):1015-23. Review.

PMID:
15516935
[PubMed - indexed for MEDLINE]
8.

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.

Gürman G, Arat M, Ilhan O, Konuk N, Beksaç M, Celebi H, Ozcan M, Arslan O, Ustün C, Akan H, Uysal A, Koç H.

Cytotherapy. 2001;3(4):253-60.

PMID:
12171713
[PubMed - indexed for MEDLINE]
9.

Vascular endothelium and graft-versus-host disease.

Biedermann BC.

Best Pract Res Clin Haematol. 2008 Jun;21(2):129-38. doi: 10.1016/j.beha.2008.02.003. Review.

PMID:
18503981
[PubMed - indexed for MEDLINE]
10.

[Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation].

Fu HX, Zhang XH.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Feb;16(1):222-6. Review. Chinese.

PMID:
18315936
[PubMed - indexed for MEDLINE]
11.

Hepatic veno-occlusive disease after stem cell transplantation in Japan.

Oh H, Takahashi S, Sakamaki S, Kato S, Okamoto S, Hiraoka A, Kasai M, Maseki N, Dohy H, Kodera Y.

Bone Marrow Transplant. 1999 Jul;24(2):223-4. No abstract available.

PMID:
10455356
[PubMed - indexed for MEDLINE]
Free Article
12.

Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications.

Nürnberger W, Michelmann I, Burdach S, Göbel U.

Ann Hematol. 1998 Feb;76(2):61-5.

PMID:
9540759
[PubMed - indexed for MEDLINE]
13.

Prediction of veno-occlusive disease using biomarkers of endothelial injury.

Cutler C, Kim HT, Ayanian S, Bradwin G, Revta C, Aldridge J, Ho V, Alyea E, Koreth J, Armand P, Soiffer R, Ritz J, Richardson PG, Antin JH.

Biol Blood Marrow Transplant. 2010 Aug;16(8):1180-5. doi: 10.1016/j.bbmt.2010.02.016. Epub 2010 Feb 23.

PMID:
20184961
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases.

Cogbill CH, Drobyski WR, Komorowski RA.

Mod Pathol. 2011 Jan;24(1):117-25. doi: 10.1038/modpathol.2010.163. Epub 2010 Oct 15.

PMID:
20953169
[PubMed - indexed for MEDLINE]
Free Article
15.

Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.

Sakaguchi H, Watanabe N, Muramatsu H, Doisaki S, Yoshida N, Matsumoto K, Kato K.

Pediatr Blood Cancer. 2010 Dec 1;55(6):1118-25. doi: 10.1002/pbc.22645.

PMID:
20589662
[PubMed - indexed for MEDLINE]
16.

Successful treatment of sinusoidal obstructive syndrome after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.

Ikezoe T, Togitani K, Komatsu N, Isaka M, Yokoyama A.

Bone Marrow Transplant. 2010 Apr;45(4):783-5. doi: 10.1038/bmt.2009.217. Epub 2009 Aug 31. No abstract available.

PMID:
19718058
[PubMed - indexed for MEDLINE]
18.

Severe metabolic abnormalities after allogeneic hematopoietic cell transplantation.

Lee JH, Choi SJ, Lee JH, Kim SE, Seol M, Lee YS, Lee JS, Kim WK, Lee KH.

Bone Marrow Transplant. 2005 Jan;35(1):63-9.

PMID:
15502852
[PubMed - indexed for MEDLINE]
19.

Stem-cell dose for allogeneic hematopoietic stem cell transplantation in hematological malignancies: is more better?

Shimoni A, Nagler A.

Leuk Lymphoma. 2009 Sep;50(9):1395-6. doi: 10.1080/10428190903174367. No abstract available.

PMID:
19672777
[PubMed - indexed for MEDLINE]
20.

Clinical importance of HLA-DPB1 in haematopoietic cell transplantation.

Shaw BE, Gooley T, Madrigal JA, Malkki M, Marsh SG, Petersdorf EW.

Tissue Antigens. 2007 Apr;69 Suppl 1:36-41.

PMID:
17445160
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk